Your.MD has closed a $30 million Series A funding round, led by Reckitt Benckiser (RB).

The investment follows an initial round of funding led by RB and existing shareholders in 2019. The new capital will enable the pre-primary care hub to expand its reach across markets - including the UK, India and the US.

Founded in 2015, Your.MD pioneered the combination of augmented intelligence with medically validated information, giving individuals personalised and relevant health tools and support to enable them to self-care when appropriate.

In the last year, Your.MD has seen significant traction after launching its COVID-19 Symptom Mapper, that helps people compare their symptoms against global norms - gathering data to help researchers from academic and public health organisations such as Imperial College London and NHSX understand the virus. The Symptom Mapper has had more than four million visits to date.

In September, the recently renamed Your.MD app, Healthily, introduced its first co-branded app in India, with Dettol.

Your.MD chief executive Matteo Berlucchi said: “Our relentless work toward democratising access to personalised healthcare information is progressing at pace and thanks to our strategic partnership with RB we are one step closer to reaching this ambitious, yet achievable, goal.”

Driving this work, alongside the existing team of over 100 digital and medical experts, is newly-appointed chief operating officer Jonathon Carr-Brown, former managing director of NHS Choices.

Three additional senior hires are Geraldine Butler-Wright, formerly of PayPal and Imperial College, as chief people and culture officer; David Gross, formerly of Canon, as chief digital officer; and Dan Kaziyev, previously at Uber, who becomes Head of data and insights.

Over the five next years, the company’s goal is to continue to evolve, expand and refine the platform, with the mission of helping one billion people find their health through self-care.

Share Story: